DIABETES, HYPERGLYCEMIA AND THE L-ARGININE/NITRIC OXIDE PATHWAY
糖尿病、高血糖和 L-精氨酸/一氧化氮途径
基本信息
- 批准号:6202450
- 负责人:
- 金额:$ 5.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
An increasing body of evidence has linked abnormalities in the
effective concentration of NO with accelerated atherosclerosis in
diabetes and other diseases. Despite this, the nature of these
abnormalities and the mechanisms by which they occur are
incompletely understood. In recent studies, we have observed that
hyperglycemia inhibits NO synthesis, as measured by arginine
conversion to citrulline, in cultured porcine aortic endothelium,
despite the fact it concurrently enhances the uptake of arginine.
In this proposal, we will attempt to define the specific
alterations in arginine transport and NO synthesis caused by
hyperglycemia and the mechanisms responsible for them. In
addition, we will examine how arginine transport and NO synthesis
are altered, in vivo, in the aorta of control and alloxan-diabetic
rabbits fed an atherogenic diet. The specific aims are as follows:
(1) To determine the effect of hyperglycemia on NO generation in
cultured endothelial cells. Arginine transport through Na+
dependent and Na-independent transporters will be characterized
and we 'will examine the relation of the two systems to NO
synthesis. We will then assess the specific effects of
hyperglycemia on these processes. To examine the implications of
cellular NOS distribution on these events, we will also carry out
analogous studies using human embryonic kidney cells stably
transfected with myrostolation-deficient and wild type eNOS. (2)
To define the changes in cell signalling and metabolism caused by
hyperglycemia and to examine their relationship to its effects on
the L-Arg/NO pathway. Changes in redox state, NADPH, DAG-PKC
signalling, and Na pump activity will be related temporally to
alterations in arginine transport and NO synthesis. In addition,
if warranted, we will examine the effects of agents that inhibit
or mimic these changes on the L-Argl/NO pathway. As part of these
studies, we will compare the effects of chronic (days) versus
acute hyperglycemia, and in collaboration with Project 1 of
modified LDL, on these events. (3) To determine how the L-Arg/NO
pathway in the intact aorta is affected by diabetes and
atherosclerosis. We will determine whether hyperglycemia causes
the same changes it does in cultured endothelium. In addition, in
concert with project 3, we will map regional differences in the
pathway in the aorta and assess whether they correlate with the
propensity of a region to develop atherosclerosis in diabetic
rabbits fed a Miller-Wilson diet. We will also determine whether
changes in the L-Arg/NO pathway antedate the appearance of
atherosclerotic lesions in these rabbits and whether they are
prevented or reversed by interventions that diminish the severity
of the atherosclerosis. These studies should provide basic
information about the regulation of arginine transport and NO
synthesis in the aortic endothelial cell and how they are altered
by hyperglycemia. In concert with the efforts of project 3, they
should also provide novel insights into the role of the L-ArgI/NO
pathway in atherosclerosis, and its acceleration by diabetes.
越来越多的证据表明,
一氧化氮有效浓度与动脉粥样硬化的关系
糖尿病和其他疾病。尽管如此,这些问题的本质
异常现象及其发生的机制是
不完全理解。在最近的研究中,我们观察到
根据精氨酸测定,高血糖抑制NO的合成
在培养的猪主动脉内皮细胞中转化为瓜氨酸,
尽管它同时增强了精氨酸的摄取。
在这项提案中,我们将尝试定义具体的
大鼠精氨酸转运和一氧化氮合成的改变
高血糖及其致病机制。在……里面
此外,我们还将研究精氨酸的转运和NO的合成
在体内,在对照组和四氧嘧啶糖尿病患者的主动脉中发生改变
给兔子喂食致动脉粥样硬化的食物。具体目标如下:
(1)观察高血糖对大鼠脑内NO生成的影响。
培养内皮细胞。精氨酸在钠离子中的转运
依赖和钠非依赖的转运蛋白将被表征
我们将研究这两个系统与NO之间的关系
综合。然后我们将评估以下各项的具体影响
高血糖对这些过程的影响。要考察以下方面的影响
关于细胞一氧化氮合酶分布的这些事件,我们还将进行
稳定使用人胚胎肾细胞的类比研究
野生型内皮型一氧化氮合酶野生型和肉豆蔻醇缺陷型。(2)
为了定义细胞信号和新陈代谢的变化,
高血糖及其与其影响的关系
L-Arg/NO通路。氧化还原状态、NADPH、DAG-PKC的变化
信号转导和钠泵活动将在时间上与
精氨酸转运和一氧化氮合成的改变。此外,
如果有必要,我们将检查抑制药物的效果
或在L-Arg1/NO通路上模拟这些变化。作为这些计划的一部分
研究,我们将比较慢性(天数)和
急性高血糖,并与
修饰的低密度脂蛋白,对这些事件。(3)确定L如何-arg/no
在完整的主动脉中的通路受到糖尿病和
动脉硬化。我们将确定高血糖是否会导致
在培养的内皮细胞中也会发生同样的变化。此外,在
与项目3协调一致,我们将绘制出
并评估它们是否与
糖尿病患者发生动脉粥样硬化的区域倾向
兔子以米勒-威尔逊饮食喂养。我们还将确定是否
L-精氨酸/一氧化氮通路的变化早于血管紧张素转换酶
这些兔的动脉粥样硬化病变以及它们是否
通过减轻严重性的干预措施来防止或逆转
动脉粥样硬化的症状。这些研究应该提供基本的
精氨酸转运和一氧化氮调节的信息
主动脉内皮细胞的合成及其如何改变
由高血糖引起。在项目3的努力下,他们
也应该为L的角色提供新的见解-Argi/no
动脉粥样硬化的途径,以及糖尿病对其加速作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEIL B RUDERMAN其他文献
NEIL B RUDERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEIL B RUDERMAN', 18)}}的其他基金
AMPK and adipose tissue biology in bariatric surgery patients
减肥手术患者的 AMPK 和脂肪组织生物学
- 批准号:
8268586 - 财政年份:2012
- 资助金额:
$ 5.58万 - 项目类别:
Oxymax System with Teadmill for Quantifying Exercise in Mice
Oxymax 系统与 Teamdmill 用于量化小鼠运动
- 批准号:
8247425 - 财政年份:2012
- 资助金额:
$ 5.58万 - 项目类别:
AMPK, Metabolic and Inflammatory Stress and the Endothelial Cell
AMPK、代谢和炎症应激以及内皮细胞
- 批准号:
8230872 - 财政年份:2011
- 资助金额:
$ 5.58万 - 项目类别:
AMPK Endothelial Cell Dysfunction and the Metabolic Syndrome (PROGRAM PROJECT)
AMPK 内皮细胞功能障碍和代谢综合征(计划项目)
- 批准号:
7805601 - 财政年份:2009
- 资助金额:
$ 5.58万 - 项目类别:
AMPK, Metabolic and Inflammatory Stress and the Endothelial Cell
AMPK、代谢和炎症应激以及内皮细胞
- 批准号:
7596513 - 财政年份:2009
- 资助金额:
$ 5.58万 - 项目类别:
AMPK Endothelial Cell Dysfunction and the Metabolic Syndrome (PROGRAM PROJECT)
AMPK 内皮细胞功能障碍和代谢综合征(计划项目)
- 批准号:
8231333 - 财政年份:2009
- 资助金额:
$ 5.58万 - 项目类别:
AMPK Endothelial Cell Dysfunction and the Metabolic Syndrome (PROGRAM PROJECT)
AMPK 内皮细胞功能障碍和代谢综合征(计划项目)
- 批准号:
8420495 - 财政年份:2009
- 资助金额:
$ 5.58万 - 项目类别:
AMPK Endothelial Cell Dysfunction and the Metabolic Syndrome (PROGRAM PROJECT)
AMPK 内皮细胞功能障碍和代谢综合征(计划项目)
- 批准号:
8020961 - 财政年份:2009
- 资助金额:
$ 5.58万 - 项目类别:
相似国自然基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
489995 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Operating Grants
The role of protein arginine methyl transferase PRMT1 on myelin development
蛋白精氨酸甲基转移酶PRMT1对髓磷脂发育的作用
- 批准号:
23K14287 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
使用 Sepiaptein 使精氨酸代谢正常化以实现 HER2 乳腺癌的免疫刺激转变
- 批准号:
10776256 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
精氨酸消耗联合铂类紫杉烷化疗对侵袭性变异前列腺癌 (AVPC) 的影响
- 批准号:
10715329 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Physiological function of arginine signaling:macropinocytosisand tumor immune evasion
精氨酸信号的生理功能:巨胞饮作用与肿瘤免疫逃避
- 批准号:
23H03317 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
498862 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Operating Grants
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Arginine methylation of the RNA helicase DDX5 in the regulation of RNA/DNA hybrids during the DNA damage response.
RNA 解旋酶 DDX5 的精氨酸甲基化在 DNA 损伤反应期间调节 RNA/DNA 杂交体中的作用。
- 批准号:
487619 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别:
Operating Grants
Regulation of and Target Recognition by Protein Arginine Methyltransferase 1 (PRMT1)
蛋白质精氨酸甲基转移酶 1 (PRMT1) 的调节和目标识别
- 批准号:
10653465 - 财政年份:2023
- 资助金额:
$ 5.58万 - 项目类别: